# The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects

> **NCT05787041** · PHASE1 · COMPLETED · sponsor: **South China Center For Innovative Pharmaceuticals** · enrollment: 16 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** high-fat diet group（AD16 20mg）
- **OTHER:** fasted group（AD16 20mg）

## Key facts

- **NCT ID:** NCT05787041
- **Lead sponsor:** South China Center For Innovative Pharmaceuticals
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-14
- **Primary completion:** 2019-12-14
- **Final completion:** 2019-12-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05787041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05787041, "The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05787041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
